We are live on
!
Find out more
RhumbLine Advisers Portfolio holdings
AUM
$117B
1-Year Est. Return
29.66%
This Fund
S&P 500
This Quarter
Est. Return
-14.6%
1 Year Est. Return
+29.66%
3 Year Est. Return
+101.47%
5 Year Est. Return
+137.35%
10 Year Est. Return
+530.92%
AUM
$68.5B
AUM Growth
-$9.16B
(-12%)
Cap. Flow
+$4.06B
Cap. Flow
% of AUM
5.93%
Top 10 Holdings %
Top 10 Hldgs %
21.45%
Holding
3,375
New
359
Increased
2,433
Reduced
285
Closed
282
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Linde
LIN
|
+$124M |
| 2 |
Apple
AAPL
|
+$110M |
| 3 |
Microsoft
MSFT
|
+$104M |
| 4 |
Amazon
AMZN
|
+$71.3M |
| 5 |
Warner Bros
WBD
|
+$69.6M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
AT&T
T
|
+$61.6M |
| 2 |
CERN
Cerner Corp
CERN
|
+$50.9M |
| 3 |
NXP Semiconductors
NXPI
|
+$31.4M |
| 4 |
AZPN
ASPEN TECHNOLOGY INC
AZPN
|
+$30.4M |
| 5 |
Yum China
YUMC
|
+$16.3M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 23.13% |
| 2 | Healthcare | 14.42% |
| 3 | Financials | 13.45% |
| 4 | Consumer Discretionary | 10.49% |
| 5 | Industrials | 9.06% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
|
EVBG
2001
DELISTED
Everbridge, Inc. Common Stock
EVBG
| $1.31M | ﹤0.01% |
46,999
+14,021
| +43% | +$568K |
|
2002
Coherus Oncology
CHRS
$196M
| $1.3M | ﹤0.01% |
180,303
+15,203
| +9% | +$132K |
|
2003
Center Bancorp
CNOB
$1.78B
| $1.3M | ﹤0.01% |
53,317
+5,969
| +13% | +$166K |
|
2004
Comstock Resources
CRK
$3.94B
| $1.3M | ﹤0.01% |
107,922
-11,808
| -10% | -$195K |
|
|
CWEN.A
2005
DELISTED
Clearway Energy Class A
CWEN.A
| $1.3M | ﹤0.01% |
40,749
-4,734
| -10% | -$147K |
|
2006
Expro Ltd
XPRO
$1.91B
| $1.3M | ﹤0.01% |
112,893
+39,998
| +55% | +$572K |
|
|
PFC
2007
DELISTED
Premier Financial Corp. Common Stock
PFC
| $1.3M | ﹤0.01% |
51,316
+1,248
| +2% | +$33.7K |
|
2008
Adaptive Biotechnologies
ADPT
$3.97B
| $1.3M | ﹤0.01% |
160,373
+64,121
| +67% | +$564K |
|
2009
LendingTree
TREE
$451M
| $1.29M | ﹤0.01% |
29,559
-238
| -0.8% | -$17.6K |
|
2010
Xometry
XMTR
$5.34B
| $1.29M | ﹤0.01% |
38,178
+14,953
| +64% | +$516K |
|
2011
State Street SPDR S&P 500 ETF Trust
SPY
$823B
| $1.29M | ﹤0.01% |
3,431
+70
| +2% | +$28.7K |
|
2012
HCI Group
HCI
$2.41B
| $1.29M | ﹤0.01% |
19,023
+400
| +2% | +$26.4K |
|
2013
Malibu Boats
MBUU
$567M
| $1.29M | ﹤0.01% |
24,461
+2,154
| +10% | +$117K |
|
2014
QCR Holdings
QCRH
$1.7B
| $1.29M | ﹤0.01% |
23,837
+4,297
| +22% | +$234K |
|
2015
Noble Corp
NE
$6.51B
| $1.28M | ﹤0.01% |
+50,669
| New | +$1.67M |
|
2016
Zentalis Pharmaceuticals
ZNTL
$302M
| $1.28M | ﹤0.01% |
45,684
+7,761
| +20% | +$206K |
|
|
KNBE
2017
DELISTED
KnowBe4, Inc. Class A Common Stock
KNBE
| $1.28M | ﹤0.01% |
+82,137
| New | +$1.61M |
|
2018
Zumiez
ZUMZ
$339M
| $1.28M | ﹤0.01% |
49,299
-7,892
| -14% | -$266K |
|
2019
BridgeBio Pharma
BBIO
$16.5B
| $1.28M | ﹤0.01% |
141,011
+17,520
| +14% | +$147K |
|
|
LOGC
2020
DELISTED
ContextLogic
LOGC
| $1.28M | ﹤0.01% |
+26,654
| New | +$1.44M |
|
|
PTRA
2021
DELISTED
Proterra Inc. Common Stock
PTRA
| $1.28M | ﹤0.01% |
+275,654
| New | +$1.69M |
|
|
FSP
2022
Franklin Street Properties
FSP
$46.8M
| $1.28M | ﹤0.01% |
306,559
-1,768
| -0.6% | -$8.48K |
|
2023
Thryv Holdings
THRY
$108M
| $1.28M | ﹤0.01% |
56,968
+24,745
| +77% | +$635K |
|
|
EVOP
2024
DELISTED
EVO Payments, Inc. Class A Common Stock
EVOP
| $1.27M | ﹤0.01% |
53,893
+3,260
| +6% | +$74.3K |
|
|
BRMK
2025
DELISTED
Broadmark Realty Capital Inc. Common Stock
BRMK
| $1.26M | ﹤0.01% |
188,288
+17,273
| +10% | +$130K |
|
Similar funds
VAM
RhumbLine Advisers's Q2 2022 Portfolio in Review
As of Q2 2022, RhumbLine Advisers held 3,375 positions worth $68.5B, down 12% from $77.7B the previous quarter. Its ten largest holdings account for 21% of the portfolio.
RhumbLine Advisers deployed $4.06B of net new capital in Q2 2022, opening 359 new positions and adding to 2,433 existing holdings. Its largest new stake was Aspen Technology Inc: 81,883 shares worth $15M.
By sector, the portfolio is most concentrated in Technology at 23% of assets, down from 25% a quarter earlier, followed by Healthcare and Financials.
On the sell side, the largest reduction was AT&T, an estimated $61.6M trimmed.
- RhumbLine Advisers's largest Q2 2022 buy was Aspen Technology Inc: 81,883 shares worth $15M.
- RhumbLine Advisers added most to Linde in Q2 2022, an estimated $124M increase.
- RhumbLine Advisers's biggest Q2 2022 reduction was AT&T, cutting an estimated $61.6M.
- RhumbLine Advisers fully exited Cerner Corp in Q2 2022, selling an estimated $50.9M.
- RhumbLine Advisers's ten largest holdings make up 21% of its $68.5B portfolio in Q2 2022.
- RhumbLine Advisers opened 359 new positions and closed 282 in Q2 2022.
- RhumbLine Advisers's portfolio value fell 12% quarter-over-quarter to $68.5B.
Based on RhumbLine Advisers's 13F filing for Q2 2022, filed 11 Aug 2022.